Total: £ 56.28
Published Date: 2024-11-05 | Pages: 162 | Tables: 283 | Food & Beverages
Aflatoxin B1 Immunoaffinity Columns (IACs) are specialized chromatographic columns designed specifically for the extraction and purification of aflatoxin B1 (AFB1) from various samples. AFB1 is one of the most significant and toxic aflatoxins produced by certain molds, particularly Aspergillus flavus and Aspergillus parasiticus.
The global market for Aflatoxin M1 Immunoaffinity Columns (IAC) was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Aflatoxin M1 Immunoaffinity Columns (IAC) was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Aflatoxin M1 Immunoaffinity Columns (IAC) include Gold Standard Diagnostics Horsham, LCTech, Shimadzu, Biotez Berlin, PerkinElmer, VICAM, Ring Biotechnology, R-Biopharm AG and CHROMATIFIC, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Aflatoxin M1 Immunoaffinity Columns (IAC), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Aflatoxin M1 Immunoaffinity Columns (IAC) by region & country, by Type, and by Application.
The Aflatoxin M1 Immunoaffinity Columns (IAC) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aflatoxin M1 Immunoaffinity Columns (IAC).
Market Segmentation
By Company
Gold Standard Diagnostics Horsham
LCTech
Shimadzu
Biotez Berlin
PerkinElmer
VICAM
Ring Biotechnology
R-Biopharm AG
CHROMATIFIC
Neogen
Kwinbon Biotechnology
Shandong Meizheng Bio-Tech
Jiangsu Wisdom Engineering & Technology
BIOCOMMA
Beijing Nano-Ace Technology
Femdetection
Wuhan Huamei Wisherkon Biotech
Changsha Huaxue Biological Technology
Anavo
Shandong Vnya Bio-technology
Guanyibio
Prufunglab
Segment by Type:
80% Below
80-90%
91-100%
100% Above
Segment by Application
Milk
Goat Milk
Soy Milk
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Aflatoxin M1 Immunoaffinity Columns (IAC) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Aflatoxin M1 Immunoaffinity Columns (IAC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Aflatoxin M1 Immunoaffinity Columns (IAC) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Product Introduction
1.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Market Size Forecast
1.2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value (2019-2030)
1.2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (2019-2030)
1.2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Price (2019-2030)
1.3 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Trends & Drivers
1.3.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Industry Trends
1.3.2 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Drivers & Opportunity
1.3.3 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Challenges
1.3.4 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Players Revenue Ranking (2023)
2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Company (2019-2024)
2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Players Sales Volume Ranking (2023)
2.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Company Players (2019-2024)
2.5 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Company (2019-2024)
2.6 Key Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Aflatoxin M1 Immunoaffinity Columns (IAC)
2.9 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Competitive Analysis
2.9.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflatoxin M1 Immunoaffinity Columns (IAC) as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 80% Below
3.1.2 80-90%
3.1.3 91-100%
3.1.4 100% Above
3.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type
3.2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, by Type (2019-2030)
3.2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, by Type (%) (2019-2030)
3.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Type
3.3.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, by Type (2019-2030)
3.3.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, by Type (%) (2019-2030)
3.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Milk
4.1.2 Goat Milk
4.1.3 Soy Milk
4.1.4 Others
4.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application
4.2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, by Application (2019-2030)
4.2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, by Application (%) (2019-2030)
4.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Application
4.3.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, by Application (2019-2030)
4.3.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, by Application (%) (2019-2030)
4.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region
5.1.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024)
5.1.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030)
5.1.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (%), (2019-2030)
5.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region
5.2.1 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024)
5.2.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030)
5.2.4 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (%), (2019-2030)
5.3 Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.4.2 North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.5.2 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.6.2 Asia Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.7.2 South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
5.8.2 Middle East & Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value
6.2.1 Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.2.2 Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.3.2 United States Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.4.2 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.5.2 China Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.5.3 China Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.6.2 Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.7.2 South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.8.2 Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019-2030
6.9.2 India Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
6.9.3 India Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Gold Standard Diagnostics Horsham
7.1.1 Gold Standard Diagnostics Horsham Company Information
7.1.2 Gold Standard Diagnostics Horsham Introduction and Business Overview
7.1.3 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.1.5 Gold Standard Diagnostics Horsham Recent Development
7.2 LCTech
7.2.1 LCTech Company Information
7.2.2 LCTech Introduction and Business Overview
7.2.3 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.2.4 LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.2.5 LCTech Recent Development
7.3 Shimadzu
7.3.1 Shimadzu Company Information
7.3.2 Shimadzu Introduction and Business Overview
7.3.3 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.3.5 Shimadzu Recent Development
7.4 Biotez Berlin
7.4.1 Biotez Berlin Company Information
7.4.2 Biotez Berlin Introduction and Business Overview
7.4.3 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.4.5 Biotez Berlin Recent Development
7.5 PerkinElmer
7.5.1 PerkinElmer Company Information
7.5.2 PerkinElmer Introduction and Business Overview
7.5.3 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.5.4 PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.5.5 PerkinElmer Recent Development
7.6 VICAM
7.6.1 VICAM Company Information
7.6.2 VICAM Introduction and Business Overview
7.6.3 VICAM Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.6.4 VICAM Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.6.5 VICAM Recent Development
7.7 Ring Biotechnology
7.7.1 Ring Biotechnology Company Information
7.7.2 Ring Biotechnology Introduction and Business Overview
7.7.3 Ring Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Ring Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.7.5 Ring Biotechnology Recent Development
7.8 R-Biopharm AG
7.8.1 R-Biopharm AG Company Information
7.8.2 R-Biopharm AG Introduction and Business Overview
7.8.3 R-Biopharm AG Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.8.4 R-Biopharm AG Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.8.5 R-Biopharm AG Recent Development
7.9 CHROMATIFIC
7.9.1 CHROMATIFIC Company Information
7.9.2 CHROMATIFIC Introduction and Business Overview
7.9.3 CHROMATIFIC Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.9.4 CHROMATIFIC Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.9.5 CHROMATIFIC Recent Development
7.10 Neogen
7.10.1 Neogen Company Information
7.10.2 Neogen Introduction and Business Overview
7.10.3 Neogen Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Neogen Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.10.5 Neogen Recent Development
7.11 Kwinbon Biotechnology
7.11.1 Kwinbon Biotechnology Company Information
7.11.2 Kwinbon Biotechnology Introduction and Business Overview
7.11.3 Kwinbon Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Kwinbon Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.11.5 Kwinbon Biotechnology Recent Development
7.12 Shandong Meizheng Bio-Tech
7.12.1 Shandong Meizheng Bio-Tech Company Information
7.12.2 Shandong Meizheng Bio-Tech Introduction and Business Overview
7.12.3 Shandong Meizheng Bio-Tech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Shandong Meizheng Bio-Tech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.12.5 Shandong Meizheng Bio-Tech Recent Development
7.13 Jiangsu Wisdom Engineering & Technology
7.13.1 Jiangsu Wisdom Engineering & Technology Company Information
7.13.2 Jiangsu Wisdom Engineering & Technology Introduction and Business Overview
7.13.3 Jiangsu Wisdom Engineering & Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Jiangsu Wisdom Engineering & Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.13.5 Jiangsu Wisdom Engineering & Technology Recent Development
7.14 BIOCOMMA
7.14.1 BIOCOMMA Company Information
7.14.2 BIOCOMMA Introduction and Business Overview
7.14.3 BIOCOMMA Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.14.4 BIOCOMMA Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.14.5 BIOCOMMA Recent Development
7.15 Beijing Nano-Ace Technology
7.15.1 Beijing Nano-Ace Technology Company Information
7.15.2 Beijing Nano-Ace Technology Introduction and Business Overview
7.15.3 Beijing Nano-Ace Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Beijing Nano-Ace Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.15.5 Beijing Nano-Ace Technology Recent Development
7.16 Femdetection
7.16.1 Femdetection Company Information
7.16.2 Femdetection Introduction and Business Overview
7.16.3 Femdetection Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Femdetection Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.16.5 Femdetection Recent Development
7.17 Wuhan Huamei Wisherkon Biotech
7.17.1 Wuhan Huamei Wisherkon Biotech Company Information
7.17.2 Wuhan Huamei Wisherkon Biotech Introduction and Business Overview
7.17.3 Wuhan Huamei Wisherkon Biotech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Wuhan Huamei Wisherkon Biotech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.17.5 Wuhan Huamei Wisherkon Biotech Recent Development
7.18 Changsha Huaxue Biological Technology
7.18.1 Changsha Huaxue Biological Technology Company Information
7.18.2 Changsha Huaxue Biological Technology Introduction and Business Overview
7.18.3 Changsha Huaxue Biological Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Changsha Huaxue Biological Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.18.5 Changsha Huaxue Biological Technology Recent Development
7.19 Anavo
7.19.1 Anavo Company Information
7.19.2 Anavo Introduction and Business Overview
7.19.3 Anavo Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Anavo Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.19.5 Anavo Recent Development
7.20 Shandong Vnya Bio-technology
7.20.1 Shandong Vnya Bio-technology Company Information
7.20.2 Shandong Vnya Bio-technology Introduction and Business Overview
7.20.3 Shandong Vnya Bio-technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Shandong Vnya Bio-technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.20.5 Shandong Vnya Bio-technology Recent Development
7.21 Guanyibio
7.21.1 Guanyibio Company Information
7.21.2 Guanyibio Introduction and Business Overview
7.21.3 Guanyibio Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.21.4 Guanyibio Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.21.5 Guanyibio Recent Development
7.22 Prufunglab
7.22.1 Prufunglab Company Information
7.22.2 Prufunglab Introduction and Business Overview
7.22.3 Prufunglab Aflatoxin M1 Immunoaffinity Columns (IAC) Sales, Revenue and Gross Margin (2019-2024)
7.22.4 Prufunglab Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
7.22.5 Prufunglab Recent Development
8 Industry Chain Analysis
8.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Industrial Chain
8.2 Aflatoxin M1 Immunoaffinity Columns (IAC) Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Model
8.5.2 Sales Channel
8.5.3 Aflatoxin M1 Immunoaffinity Columns (IAC) Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Aflatoxin M1 Immunoaffinity Columns (IAC) Market Trends
Table 2. Aflatoxin M1 Immunoaffinity Columns (IAC) Market Drivers & Opportunity
Table 3. Aflatoxin M1 Immunoaffinity Columns (IAC) Market Challenges
Table 4. Aflatoxin M1 Immunoaffinity Columns (IAC) Market Restraints
Table 5. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue Market Share by Company (2019-2024)
Table 7. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Aflatoxin M1 Immunoaffinity Columns (IAC) Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Aflatoxin M1 Immunoaffinity Columns (IAC) Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Aflatoxin M1 Immunoaffinity Columns (IAC)
Table 13. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aflatoxin M1 Immunoaffinity Columns (IAC) as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (2019-2024) & (%)
Table 44. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Region (2025-2030) & (%)
Table 45. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (2019-2024) & (%)
Table 49. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Region (2025-2030) & (%)
Table 50. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume, (2025-2030) & (K Units)
Table 57. Gold Standard Diagnostics Horsham Company Information
Table 58. Gold Standard Diagnostics Horsham Introduction and Business Overview
Table 59. Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Gold Standard Diagnostics Horsham Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 61. Gold Standard Diagnostics Horsham Recent Development
Table 62. LCTech Company Information
Table 63. LCTech Introduction and Business Overview
Table 64. LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. LCTech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 66. LCTech Recent Development
Table 67. Shimadzu Company Information
Table 68. Shimadzu Introduction and Business Overview
Table 69. Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Shimadzu Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 71. Shimadzu Recent Development
Table 72. Biotez Berlin Company Information
Table 73. Biotez Berlin Introduction and Business Overview
Table 74. Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Biotez Berlin Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 76. Biotez Berlin Recent Development
Table 77. PerkinElmer Company Information
Table 78. PerkinElmer Introduction and Business Overview
Table 79. PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. PerkinElmer Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 81. PerkinElmer Recent Development
Table 82. VICAM Company Information
Table 83. VICAM Introduction and Business Overview
Table 84. VICAM Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. VICAM Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 86. VICAM Recent Development
Table 87. Ring Biotechnology Company Information
Table 88. Ring Biotechnology Introduction and Business Overview
Table 89. Ring Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Ring Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 91. Ring Biotechnology Recent Development
Table 92. R-Biopharm AG Company Information
Table 93. R-Biopharm AG Introduction and Business Overview
Table 94. R-Biopharm AG Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. R-Biopharm AG Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 96. R-Biopharm AG Recent Development
Table 97. CHROMATIFIC Company Information
Table 98. CHROMATIFIC Introduction and Business Overview
Table 99. CHROMATIFIC Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. CHROMATIFIC Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 101. CHROMATIFIC Recent Development
Table 102. Neogen Company Information
Table 103. Neogen Introduction and Business Overview
Table 104. Neogen Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Neogen Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 106. Neogen Recent Development
Table 107. Kwinbon Biotechnology Company Information
Table 108. Kwinbon Biotechnology Introduction and Business Overview
Table 109. Kwinbon Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Kwinbon Biotechnology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 111. Kwinbon Biotechnology Recent Development
Table 112. Shandong Meizheng Bio-Tech Company Information
Table 113. Shandong Meizheng Bio-Tech Introduction and Business Overview
Table 114. Shandong Meizheng Bio-Tech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Shandong Meizheng Bio-Tech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 116. Shandong Meizheng Bio-Tech Recent Development
Table 117. Jiangsu Wisdom Engineering & Technology Company Information
Table 118. Jiangsu Wisdom Engineering & Technology Introduction and Business Overview
Table 119. Jiangsu Wisdom Engineering & Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Jiangsu Wisdom Engineering & Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 121. Jiangsu Wisdom Engineering & Technology Recent Development
Table 122. BIOCOMMA Company Information
Table 123. BIOCOMMA Introduction and Business Overview
Table 124. BIOCOMMA Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. BIOCOMMA Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 126. BIOCOMMA Recent Development
Table 127. Beijing Nano-Ace Technology Company Information
Table 128. Beijing Nano-Ace Technology Introduction and Business Overview
Table 129. Beijing Nano-Ace Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Beijing Nano-Ace Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 131. Beijing Nano-Ace Technology Recent Development
Table 132. Femdetection Company Information
Table 133. Femdetection Introduction and Business Overview
Table 134. Femdetection Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. Femdetection Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 136. Femdetection Recent Development
Table 137. Wuhan Huamei Wisherkon Biotech Company Information
Table 138. Wuhan Huamei Wisherkon Biotech Introduction and Business Overview
Table 139. Wuhan Huamei Wisherkon Biotech Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 140. Wuhan Huamei Wisherkon Biotech Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 141. Wuhan Huamei Wisherkon Biotech Recent Development
Table 142. Changsha Huaxue Biological Technology Company Information
Table 143. Changsha Huaxue Biological Technology Introduction and Business Overview
Table 144. Changsha Huaxue Biological Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 145. Changsha Huaxue Biological Technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 146. Changsha Huaxue Biological Technology Recent Development
Table 147. Anavo Company Information
Table 148. Anavo Introduction and Business Overview
Table 149. Anavo Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 150. Anavo Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 151. Anavo Recent Development
Table 152. Shandong Vnya Bio-technology Company Information
Table 153. Shandong Vnya Bio-technology Introduction and Business Overview
Table 154. Shandong Vnya Bio-technology Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 155. Shandong Vnya Bio-technology Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 156. Shandong Vnya Bio-technology Recent Development
Table 157. Guanyibio Company Information
Table 158. Guanyibio Introduction and Business Overview
Table 159. Guanyibio Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 160. Guanyibio Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 161. Guanyibio Recent Development
Table 162. Prufunglab Company Information
Table 163. Prufunglab Introduction and Business Overview
Table 164. Prufunglab Aflatoxin M1 Immunoaffinity Columns (IAC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 165. Prufunglab Aflatoxin M1 Immunoaffinity Columns (IAC) Product Offerings
Table 166. Prufunglab Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Aflatoxin M1 Immunoaffinity Columns (IAC) Downstream Customers
Table 170. Aflatoxin M1 Immunoaffinity Columns (IAC) Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Aflatoxin M1 Immunoaffinity Columns (IAC) Product Picture
Figure 2. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (2019-2030) & (K Units)
Figure 5. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Price (2019-2030) & (US$/Unit)
Figure 6. Aflatoxin M1 Immunoaffinity Columns (IAC) Report Years Considered
Figure 7. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Aflatoxin M1 Immunoaffinity Columns (IAC) Revenue in 2023
Figure 10. Aflatoxin M1 Immunoaffinity Columns (IAC) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. 80% Below Picture
Figure 12. 80-90% Picture
Figure 13. 91-100% Picture
Figure 14. 100% Above Picture
Figure 15. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Milk
Figure 21. Product Picture of Goat Milk
Figure 22. Product Picture of Soy Milk
Figure 23. Product Picture of Others
Figure 24. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 25. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value Market Share by Application, 2023 & 2030
Figure 26. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 27. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume Market Share by Application, 2023 & 2030
Figure 28. Global Aflatoxin M1 Immunoaffinity Columns (IAC) Price by Application (2019-2030) & (US$/Unit)
Figure 29. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 30. North America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 31. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 32. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 33. Asia Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 35. South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 36. South America Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 37. Middle East & Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value (2019-2030) & (US$ Million)
Figure 38. Middle East & Africa Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Country (%), 2023 VS 2030
Figure 39. Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value (%), (2019-2030)
Figure 40. Key Countries/Regions Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Volume (%), (2019-2030)
Figure 41. United States Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 42. United States Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 43. United States Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 44. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 45. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 46. Europe Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 47. China Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 48. China Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 49. China Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 50. Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 51. Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 52. Japan Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 53. South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 54. South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 55. South Korea Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 56. Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 57. Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 58. Southeast Asia Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 59. India Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value, (2019-2030) & (US$ Million)
Figure 60. India Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Type (%), 2023 VS 2030
Figure 61. India Aflatoxin M1 Immunoaffinity Columns (IAC) Sales Value by Application (%), 2023 VS 2030
Figure 62. Aflatoxin M1 Immunoaffinity Columns (IAC) Industrial Chain
Figure 63. Aflatoxin M1 Immunoaffinity Columns (IAC) Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed